One, Project Overview
BIO Protocol is an innovative platform for decentralized science (DeSci), dedicated to funding and commercializing scientific research in the biotechnology field. Through this protocol, global patients, scientists, and biotechnology investors can collaboratively fund, create, and own tokenized biotechnology projects and intellectual property (IP), thereby accelerating advancements in biotechnology.
BIO Protocol aims to address many pain points in traditional scientific funding and the commercialization of biotechnology, including time-consuming funding processes, the 'Valley of Death' for early research outcomes, funding centralization, intellectual property barriers, and insufficient patient engagement. Through decentralized funding models, capital efficiency improvements, global resource integration, and shared intellectual property, BIO Protocol is injecting new vitality into biotechnology innovation.
Two, Market Pain Points and Solutions of BIO Protocol
1. Market Pain Points
Time-consuming funding processes: Scientists spend a significant amount of time applying for funding, impacting research efficiency.
The 'Valley of Death' phenomenon: Many early discoveries fail to commercialize due to high risks, lack of resources, and insufficient support.
Funding centralization: Research funds are concentrated in a few geographic areas, limiting the potential of global scientific talent.
Complex intellectual property barriers: Fragmented ownership of intellectual property and licensing agreements hinder collaboration and innovation.
Insufficient patient engagement: Most research is disconnected from patient communities, failing to establish consistent incentive mechanisms.
2. Solutions of BIO Protocol
Decentralized Funding: Allows anyone to invest in promising biotechnology projects.
Capital Efficiency Improvement: Aggregating patient data, capital, and human resources to reduce innovation costs.
Diversified Portfolio: Reducing biotechnology investment risks through portfolio investments.
Global Resource Integration: Attracting global scientists and investors to participate in projects.
Shared Intellectual Property: Achieving joint ownership of intellectual property through tokenization.
Liquidity Market: Providing early liquidity for traditionally illiquid biotechnology assets.
Open Rights: Eliminating intermediaries in scientific funding and decision-making.
Three, Core Functions of BIO Protocol
1. BIO Launchpad
BIO Launchpad is one of the core functions of BIO Protocol, divided into three phases:
Governance Phase: BIO holders vote to decide which BioDAO projects can be launched through BIO Protocol.
Acceleration Phase: Projects raise their first funds through auctions or joint curve mechanisms.
Separation Phase: Projects enter the public market through on-chain liquidity pools, with BIO Protocol providing liquidity support.
2. BioDAO Launchpad
BIO Protocol supports the creation and development of BioDAO, helping establish legal governance frameworks, brand development, and deployment of Web3 tools. BIO provides funding support and AI tools to BioDAO through partnerships with Catalyst and Pump.science.
3. Liquidity Protocols
BIO Protocol provides deep on-chain liquidity pools, supporting liquidity trading between BioDAO tokens and ETH, facilitating the healthy development of the DeSci ecosystem.
4. Tokenized Intellectual Property
BIO Protocol tokenizes scientific intellectual property, granting it liquidity, enabling investors to participate in the value creation of biotechnology assets earlier.
Four, Token Economics of BIO Protocol
1. Token Allocation
The governance token of BIO Protocol is BIO, following the ERC-20 standard, with a total supply of 3,320,000,000 tokens, allocated as follows:
Team: 21.20%
Advisors: 4.70%
Private Investors: 13.60%
Community Auction: 20.00%
Community Airdrop: 6.00%
Ecosystem Incentives: 19.00%
Liquidity and Marketing: 2.50%
Binance Launchpool: 3.00%
2. Token Functionality
Governance Rights: BIO holders can participate in protocol governance, including the meta-governance of BioDAO.
Whitelist Access: BIO holders have priority to participate in BioDAO funding rounds and investment opportunities for tokenized IP.
Curatorial Management: BIO holders decide which BioDAO projects can be launched through BIO Launchpad.
Protocol Liquidity: BIO Protocol utilizes BioDAO tokens and IP tokens in its treasury to provide liquidity and earn transaction fees.
3. Token Issuance Timeline
BIO Protocol uses a phased token release approach to ensure market stability and healthy ecosystem development.
Five, Financing Situation and Key Indicators
1. Financing Situation
BIO Protocol has completed multiple rounds of private and public financing:
Private Financing:
Pre-seed Round: Raised $900,000, with a valuation of about $35 million.
Seed Round: Raised $1.4 million, with a valuation of about $69 million.
Public Financing:
Genesis Round 1: Raised $6.2 million, with a valuation of about $85 million.
Genesis Round 2: Raised $18.2 million, with a valuation of about $142 million.
Genesis Round 2.5: Raised $3.5 million, with a valuation of about $219 million.
2. Key Indicators (as of December 24, 2024)
Initial Circulation: 1,296,529,168 tokens (39.05% of total supply)
Maximum Circulation: 3,320,000,000 tokens
Binance Launchpool Quota: 99,600,000 tokens (3.00% of total supply)
Six, Roadmap and Future Plans
1. Completed Milestones
Q2 2024: Launch of BIO protocol and community airdrop.
Q3-Q4 2024: Completion of multiple rounds of Genesis auctions.
Q4 2024: Launch of DeSci dashboard and Quantum Biology auction.
2. Future Plans
January 2025:
Launch on centralized exchanges (CEX).
Launch of DeSci AI agents.
Release of $BIO on Ethereum, Solana, and Base chains.
Launch of $BIO/BioDAO liquidity pool.
February 2025:
Launch of BIO Launchpad v1.
Deploying management mechanisms on EVM chains and Solana.
Launching the Curetopia platform.
Seven, Business Cooperation and Ecosystem
BIO Protocol actively collaborates with industry-leading institutions to jointly promote the development of the DeSci ecosystem:
Molecule AG: Provides IP-NFT and IP tokenization frameworks.
ResearchHub: Supports a decentralized peer review platform.
Pump.Science: Provides distributed research protocol services.
Pfizer Ventures: Promotes the commercialization of biotechnology projects.
Eight, Summary and Analysis
BIO Protocol is a pioneer in decentralized science, addressing pain points in scientific funding and biotechnology commercialization through tokenization and decentralization. Its core functions, BIO Launchpad and liquidity protocols, provide strong support for biotechnology innovation, while attracting a wide range of investors and scientists through token economics and global resource integration.
From a future development perspective, BIO Protocol's roadmap is clear, with specific goals, particularly demonstrating great potential in areas such as DeSci AI agents, cross-chain deployment, and the Curetopia platform. As the BIO Protocol ecosystem continues to grow, its influence in the field of decentralized science will also keep increasing.
Overall, BIO Protocol is a project with disruptive potential, bringing new possibilities for scientific research and the commercialization of biotechnology, while providing global investors with opportunities to participate in cutting-edge research.
Note:
My invitation link: https://www.suitechsui.io/cn/join?ref=HYERS7S4
#Binance